Showing 48 out of 97 results
COVID-19: ÁREAS DE IMPACTO: Últimas novedades en el sector farmacéutico y salud (España)
Detallamos a continuación las últimas órdenes en relación con la gestión de la crisis de la COVID-19 en materia del sector farmacéutico y …
Exploring Opportunities: The impact of Covid-19 on competition law in the pharmaceutical sector (Europe)
The global Covid-19 pandemic has, to an extent, re-directed some of the actions and focus of competition authorities, which are placing increasing …
COVID-19: Pressure points: Online sales of pharmaceuticals – now available? (Russia)
In light of the volatile situation with COVID-19, the President of Russia signed Decree No. 187 dated 17 March 2020 “On Retail Trade of Medicines for …
Patent and Pharma Update, February 2020
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector In this issue we report on the Supreme Court …
ECJ rules for the first time on “pay-for-delay” agreements
On 30 January 2020 the European Court of Justice (“ECJ”) clarified for the first time the criteria governing whether so-called “pay-for-delay” agreements …
Leading pharmaceutical lawyer joins Herbert Smith Freehills in Madrid
Herbert Smith Freehills has added to its European pharmaceuticals platform with the hire of leading Spanish lawyer Lourdes Fraguas to the firm's Madrid …
Big data is transforming investigations
Big data is rapidly changing the way in which regulators and law enforcement conduct an investigation and build a case. New technology reduces compliance …
The ACCC pilots its first ‘effect test’ in misuse of market power proceedings
On 6 December 2019, the ACCC launched its first enforcement proceedings under the new ‘effects test’ prohibition on misuse of market power. The …
Medicines for the Many – a reaction from Herbert Smith Freehills
Responding to the publication of the Labour Party's manifesto and the 'Medicines for the Many' report – the Party's proposed policies on access to …
Herbert Smith Freehills Advises Abcam on acquisition of Expedeon's proteomics and immunology business
Leading global law firm Herbert Smith Freehills is advising Abcam on its acquisition of Expedeon AG's proteomics and immunology business. The transaction …
HERBERT SMITH FREEHILLS ADVISES ON LUPIN'S DIVESTMENT OF KYOWA PHARMACEUTICAL
Leading global law firm Herbert Smith Freehills is advising Nanomi B.V., a subsidiary of Lupin Limited, on the sale of its entire stake in its Japanese …
Herbert Smith Freehills advises on second Hong Kong pharma IPO in less than one week
Leading global law firm Herbert Smith Freehills has advised the joint sponsors of the IPO of SinoMab BioScience Limited on the Main Board of the Stock …
Showing 48 out of 97 results
View more